Skip to main content
Top

International Journal of Hematology

Issue 1/2022

Including PIH articles on Current status and future perspectives of allogeneic hematopoietic cell transplantation for non-malignant diseases

Content (20 Articles)

Lymphoma Images in Hematology

Diffuse 18F-fluorodeoxyglucose uptake in the bone marrow of an elderly man with B-cell lymphoma

Kenki Saito, Kenji Notohara, Etsuro Sakata, Koya Nakatani, Yasunori Ueda

Immunodeficiency Progress in Hematology

Conditioning regimens for inborn errors of immunity: current perspectives and future strategies

Akira Nishimura, Satoshi Miyamoto, Kohsuke Imai, Tomohiro Morio

Vaccination Rapid Communication

Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria

Yuya Kamura, Tatsuhiro Sakamoto, Yasuhisa Yokoyama, Hidekazu Nishikii, Mamiko Sakata-Yanagimoto, Shigeru Chiba, Naoshi Obara

Sectio Ceasarea Original Article

Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol

Mamoru Morikawa, Masahiro Ieko, Kinuko Nakagawa-Akabane, Takeshi Umazume, Kentaro Chiba, Satoshi Kawaguchi, Michinori Mayama, Yoshihiro Saito, Hidemichi Watari

Acute Myeloid Leukemia Original Article

Companion gene mutations and their clinical significance in AML with double or single mutant CEBPA

JinYuan He, Jie Liu, HongJie Shen, Zheng Wang, LiuJun Cao, Pin Wu, HongYing Chao, XuZhang Lu, ZhuXia Jia, MeiYu Chen, Xiaohui Cai

Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes

Hiroto Yanagisawa, Hiroshi Kawabata, Yusuke Ueda, Kotaro Arita, Haruka Iwao-Kawanami, Tomoyuki Sakai, Takafumi Kawanami, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki

Acute Myeloid Leukemia Original Article

Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy

Chikashi Yoshida, Takeshi Kondo, Tomoki Ito, Masahiro Kizaki, Kazuhiko Yamamoto, Toshihiro Miyamoto, Yasuyoshi Morita, Tetsuya Eto, Yuna Katsuoka, Naoki Takezako, Nobuhiko Uoshima, Kazunori Imada, Jun Ando, Takuya Komeno, Akio Mori, Yuichi Ishikawa, Atsushi Satake, Junichi Watanabe, Yoshiko Kawakami, Tetsuo Morita, Ikue Taneike, Masahiko Nakayama, Yinghui Duan, Belen Garbayo Guijarro, Alexander Delgado, Cynthia Llamas, Hitoshi Kiyoi

Pleural Effusion Original Article

Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosis

Wanying Cheng, Xin Gao, Guangli Yin, Jiayu Huang, Changfeng Man, Hongxia Qiu

Multiple Myeloma Original Article

Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)

Kihyun Kim, Jin Seok Kim, Sung-Soo Yoon, Dok Hyun Yoon, Hyeon-Seok Eom, Je-Jung Lee, Hyeon Woo Yim, Misun Park, Hojoon Lee, Chang-Ki Min

Multiple Myeloma Original Article

Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment

Kosei Matsue, Kazutaka Sunami, Morio Matsumoto, Junya Kuroda, Isamu Sugiura, Hiromi Iwasaki, Weiyuan Chung, Shigeki Kuwayama, Mitsufumi Nishio, Kim Lee, Shinsuke Iida

Ponatinib in pediatric patients with Philadelphia chromosome-positive leukemia: a retrospective survey of the Japan Children’s Cancer Group

Yuichi Kodama, Atsushi Sato, Keisuke Kato, Hirotoshi Sakaguchi, Motohiro Kato, Hirohide Kawasaki, Hidefumi Hiramatsu, Itaru Kato, Takashi Taga, Hiroyuki Shimada

Lymphoma Case Report

Chronic active Epstein–Barr virus infection presenting as refractory chronic sinusitis

Wataru Kitamura, Hideaki Fujiwara, Akifumi Matsumura, Takaya Higaki, Rei Shibata, Tomohiro Toji, Soichiro Fujii, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Ken-ichi Matsuoka, Tadashi Yoshino, Yoshinobu Maeda

Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases

Shengqin Cheng, Peifang Xiao, Juxiang Wang, Zhiheng Li, Li Gao, Jiajia Zheng, Yixin Hu, Xin Ding, Jing Ling, Qin Lu, Jian Pan, Bohan Li, Jun Lu, Yi Wang, Raul C. Ribeiro, Shaoyan Hu

Anticoagulant Letter to the Editor

Lupus anticoagulant-hypoproaccelerin (factor V) syndrome (LAHPS-V): a new hemorrhagic condition associated with lupus anticoagulant

Masahiro Ieko, Sumiyoshi Naito, Mika Yoshida, Kazumasa Ohmura, Nobuhiko Takahashi, Norifumi Sugawara, Kazuki Kiyohara, Kenji Shimosegawa, Akitada Ichinose

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine